Dr. Meena Ramchandani, MD

Dr. Ramchandani practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Ramchandani's NPI, 1518294255, was assigned on November 17, 2009. Dr. Ramchandani holds Washington license 60284893.

Dr. Ramchandani's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Ramchandani's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Ramchandani to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramchandani practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Ramchandani's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Ramchandani is licensed in Washington.

CMS data shows 47 Medicare services from Dr. Ramchandani across 2 procedure codes in 2024, for 24 Medicare patients. Medicare paid $1,139 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 24 Medicare patients who saw Dr. Ramchandani in 2024. 67% of them have alcohol and drug use disorders, and 63% have tobacco use. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramchandani's median patient age at 45, with 23% women.

In 2024, Dr. Ramchandani wrote 475 Medicare Part D claims for 32 patients. 62% of them were for generic drugs. CMS names the drug for 245 of them, across 13 drugs with 11 or more claims each, at $311,497 in total drug cost. In 2023, CMS named 172 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Ramchandani for performance year 2024, reported through an alternative payment model (APM). Dr. Ramchandani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 39 papers to Dr. Ramchandani, published from 2016 to 2025. 2024 was the busiest year, with 8. The most frequent topics are HIV Infections, Homosexuality, Male and Sexual Health. Dr. Ramchandani has published most often in Sex Transm Dis. Dr. Ramchandani's most frequent co-authors are Matthew Robert Golden, MD, Julia Cook Dombrowski, MD and Eric Jessen Chow, MD.

CMS Open Payments shows 6 general payments to Dr. Ramchandani from 1 drug or device company from 2024 to 2025. Consulting fees make up the largest share, 53% of the total. La Jolla Pharmaceutical Company paid the most, $1,531.